Blloom

Three questions to the project team

What was the particular challenge of the project from a UX point of view?
The greatest UX challenge in Blloom was transforming a fearful, complex self-injection process into a natural experience anyone can perform anywhere. Existing devices emphasize technical accuracy under ISO 11608, yet users still face needle phobia, operational burden, and the stress of keeping medication at 2 to 8 degrees Celsius. Fertility treatment adds up to three daily injections and strict timing, with almost no solutions for IVF patients. We reframed UX as a psychological, behavioral, and physical challenge. Blloom reduces fear by minimizing needle visibility, enables one-button injection, and maintains drug temperature with PCM cooling. Its core challenge was merging medical reliability with emotional safety in a single device.

What was your personal highlight in the development process? Was there an aha!-moment, was there a low point?
One of the most memorable moments in developing Blloom was seeing the pain points from interviews become tangible through role-playing. Users often had to inject in public restrooms and found carrying a bulky cold pack so inconvenient that they avoided going out during treatment. By reenacting the outdoor injection process, we discovered that the real challenge was not the injection itself but the entire workflow of preparing medication, keeping it at the right temperature, and needing both hands. This shifted our focus from a single action to the emotional journey of self injection and became a key aha moment. Experiencing these issues through embodied role-play helped us understand users deeply and guided the UX direction of Blloom.

Where do you see yourself and the project in the next five years?
Over the next five years, I hope Blloom grows from a design concept into a commercially available medical device used in real clinical settings. The infertility treatment market is growing at over 6% annually and is expected to reach EUR 22.4 billion by 2028, showing strong potential. We plan to work with medical device companies and pharmaceutical partners to advance commercialization, clinical validation, and regulatory approval across regions including MFDS, FDA, and CE. Expert feedback has also highlighted the unmet need for solutions that support medication cooling and simplify self-injection. Personally, I hope to continue growing as a designer driving healthcare UX innovation, with Blloom as a meaningful first milestone.